Paradeep Phosphates Q2 FY27: consolidated revenue Rs 7,364.06 cr, PAT Rs 121.01 cr
Results$PARADEEP

Paradeep Phosphates Q2 FY27: consolidated revenue Rs 7,364.06 cr, PAT Rs 121.01 cr

For the quarter ended 30 September 2026, Paradeep Phosphates’ consolidated revenue was Rs 7,364.06 cr and PAT Rs 121.01 cr, versus Rs 6,872.20 cr and Rs 341.94 cr a year earlier.

Paradeep Phosphates Ltd
Paradeep Phosphates LtdReviewed and published by · How we report
2 min read
paradeep phosphatesq2 resultsfertilisersearningsindia
ShareWhatsAppXLinkedIn

Key takeaways

  • Revenue from operations Rs 7,364.06 cr vs Rs 6,872.20 cr a year earlier.
  • PAT Rs 121.01 cr for Q2 FY27 vs Rs 341.94 cr in Q2 FY26.
  • Total income Rs 7,381.81 cr vs Rs 6,913.91 cr in the year-ago quarter.
  • Total expenses Rs 7,217.64 cr vs Rs 6,445.39 cr a year earlier.
  • Basic EPS Rs 1.16 vs Rs 3.30 in the corresponding quarter last year.

Q2 FY27 · consolidated

MetricSep 2026Sep 2025Change
RevenueRs 7,364.06 crRs 6,872.20 cr+7.2%
PATRs 121.01 crRs 341.94 cr-64.6%

As reported in the filing. Figures are transcribed, not computed.

What the numbers show

  • Net margin was 1.64% of revenue, down 333 bps from 4.98%.
  • Total expenses rose 12.0% while revenue rose 7.2%.
  • Purchases of stock-in-trade took 45.6% of revenue, against 28.8% a year earlier.

• Basis: Consolidated statement of financial results for the quarter ended 30 September 2026, compared with the quarter ended 30 September 2025 (both unaudited), as per the statement of unaudited consolidated financial results.

• Revenue from operations: Rs 7,364.06 cr (Q2 FY27) vs Rs 6,872.20 cr (Q2 FY26).

• Other income: Rs 17.75 cr vs Rs 41.71 cr.

• Total income: Rs 7,381.81 cr vs Rs 6,913.91 cr.

• Cost of raw materials consumed: Rs 3,169.41 cr vs Rs 3,236.61 cr.

• Purchases of stock-in-trade: Rs 3,356.20 cr vs Rs 1,980.12 cr.

• Changes in inventories of finished goods, stock-in-trade and work in progress: Rs (548.95) cr vs Rs 44.53 cr.

• Employee benefits expense: Rs 83.65 cr vs Rs 81.94 cr.

• Finance costs: Rs 158.02 cr vs Rs 140.25 cr.

• Depreciation and amortisation expenses: Rs 109.01 cr vs Rs 89.58 cr.

• Other expenses: Rs 890.10 cr vs Rs 872.36 cr.

• Total expenses: Rs 7,217.64 cr vs Rs 6,445.39 cr.

• Profit before share of profit/(loss) from equity accounted investment, exceptional items and tax: Rs 164.17 cr vs Rs 468.52 cr.

• Share of profit/(loss) from associate: Rs 0.00 cr vs Rs 0.01 cr.

• Profit before exceptional items and tax: Rs 164.17 cr vs Rs 468.53 cr.

• Exceptional items: Rs 0.00 cr vs Rs 0.00 cr.

• Profit before tax: Rs 164.17 cr vs Rs 468.53 cr.

• Current tax: Rs 34.51 cr vs Rs 118.92 cr.

• Income tax charge/(credit) of earlier periods/year: Rs 0.01 cr vs Rs 0.00 cr.

• Deferred tax charge: Rs 8.64 cr vs Rs 7.67 cr.

• Total tax expense: Rs 43.16 cr vs Rs 126.59 cr.

• Profit for the period/year: Rs 121.01 cr vs Rs 341.94 cr.

• Earnings per equity share (basic): Rs 1.16 vs Rs 3.30.

• Earnings per equity share (diluted): Rs 1.16 vs Rs 3.29.

For the six months ended 30 September 2026, consolidated revenue from operations was Rs 11,488.31 cr compared with Rs 11,175.70 cr for the six months ended 30 September 2025, as per the statement of unaudited consolidated financial results. Total income for the six months ended 30 September 2026 was Rs 13,527.63 cr vs Rs 11,451.46 cr a year earlier.

Total expenses for the six months ended 30 September 2026 were Rs 12,859.04 cr vs Rs 10,558.56 cr for the six months ended 30 September 2025. Profit before tax for the six months ended 30 September 2026 stood at Rs 690.33 cr compared with Rs 892.40 cr for the six months ended 30 September 2025, and profit for the period/year was Rs 513.55 cr vs Rs 658.69 cr over the same comparative six‑month periods, according to the statement of unaudited consolidated financial results.

Track Paradeep Phosphates Ltd

Cruxal reads every Paradeep Phosphates Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.